Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation.

Annavajhala MK, Gomez-Simmonds A, Macesic N, Sullivan SB, Kress A, Khan SD, Giddins MJ, Stump S, Kim GI, Narain R, Verna EC, Uhlemann AC.

Nat Commun. 2019 Oct 17;10(1):4715. doi: 10.1038/s41467-019-12633-4.

2.

Emergence of Polymyxin Resistance in Clinical Klebsiella pneumoniae Through Diverse Genetic Adaptations: A Genomic, Retrospective Cohort Study.

Macesic N, Nelson B, Mcconville TH, Giddins MJ, Green DA, Stump S, Gomez-Simmonds A, Annavajhala MK, Uhlemann AC.

Clin Infect Dis. 2019 Sep 12. pii: ciz623. doi: 10.1093/cid/ciz623. [Epub ahead of print]

PMID:
31513705
3.

Escherichia coli Harboring mcr-1 in a Cluster of Liver Transplant Recipients: Detection through Active Surveillance and Whole-Genome Sequencing.

Macesic N, Khan S, Giddins MJ, Freedberg DE, Whittier S, Green DA, Furuya EY, Verna EC, Annavajhala MK, Gomez-Simmonds A, Uhlemann AC.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02680-18. doi: 10.1128/AAC.02680-18. Print 2019 Jun.

4.

Clonal Background, Resistance Gene Profile, and Porin Gene Mutations Modulate In Vitro Susceptibility to Imipenem-Relebactam in Diverse Enterobacteriaceae.

Gomez-Simmonds A, Stump S, Giddins MJ, Annavajhala MK, Uhlemann AC.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00573-18. doi: 10.1128/AAC.00573-18. Print 2018 Aug.

5.

Genomic and Geographic Context for the Evolution of High-Risk Carbapenem-Resistant Enterobacter cloacae Complex Clones ST171 and ST78.

Gomez-Simmonds A, Annavajhala MK, Wang Z, Macesic N, Hu Y, Giddins MJ, O'Malley A, Toussaint NC, Whittier S, Torres VJ, Uhlemann AC.

mBio. 2018 May 29;9(3). pii: e00542-18. doi: 10.1128/mBio.00542-18.

6.

Genomic Surveillance Reveals Diversity of Multidrug-Resistant Organism Colonization and Infection: A Prospective Cohort Study in Liver Transplant Recipients.

Macesic N, Gomez-Simmonds A, Sullivan SB, Giddins MJ, Ferguson SA, Korakavi G, Leeds D, Park S, Shim K, Sowash MG, Hofbauer M, Finkel R, Hu Y, West J, Toussaint NC, Greendyke WG, Miko BA, Pereira MR, Whittier S, Verna EC, Uhlemann AC.

Clin Infect Dis. 2018 Aug 31;67(6):905-912. doi: 10.1093/cid/ciy199.

7.

Barrett's esophagus is associated with a distinct oral microbiome.

Snider EJ, Compres G, Freedberg DE, Giddins MJ, Khiabanian H, Lightdale CJ, Nobel YR, Toussaint NC, Uhlemann AC, Abrams JA.

Clin Transl Gastroenterol. 2018 Feb 20;9(3):135. doi: 10.1038/s41424-018-0005-8.

8.

Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates.

Giddins MJ, Macesic N, Annavajhala MK, Stump S, Khan S, McConville TH, Mehta M, Gomez-Simmonds A, Uhlemann AC.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02101-17. doi: 10.1128/AAC.02101-17. Print 2018 Mar.

9.

Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC β-Lactamase-Producing Enterobacteriaceae.

Cheng L, Nelson BC, Mehta M, Seval N, Park S, Giddins MJ, Shi Q, Whittier S, Gomez-Simmonds A, Uhlemann AC.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00276-17. doi: 10.1128/AAC.00276-17. Print 2017 Jun.

10.

Identifying Factors and Techniques to Decrease the Positive Margin Rate in Partial Mastectomies: Have We Missed the Mark?

Edwards SB, Leitman IM, Wengrofsky AJ, Giddins MJ, Harris E, Mills CB, Fukuhara S, Cassaro S.

Breast J. 2016 May;22(3):303-9. doi: 10.1111/tbj.12573. Epub 2016 Feb 7.

PMID:
26854189

Supplemental Content

Loading ...
Support Center